These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1636581)

  • 1. Washout of long-term treatment with flecainide and propafenone in patients with complex ventricular arrhythmias and cardiac disease. Antiarrhythmic Drug Evaluation Group.
    Vincenti A; Landolina M; Latini R; Cavalli A; Gaita F; Giani P
    Am Heart J; 1992 Aug; 124(2):374-80. PubMed ID: 1636581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicentre, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Antiarrhythmic Drug Evaluation Group (A.D.E.G.).
    Eur Heart J; 1992 Sep; 13(9):1251-8. PubMed ID: 1396837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart rate variability in patients with ventricular arrhythmias: effect of antiarrhythmic drugs. Antiarrhythmic Drug Evaluation Group (ADEG).
    Zuanetti G; Latini R; Neilson JM; Schwartz PJ; Ewing DJ
    J Am Coll Cardiol; 1991 Mar; 17(3):604-12. PubMed ID: 1899680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
    Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class IC drugs: propafenone and flecainide.
    Puech P; Gagnol JP
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():549-53. PubMed ID: 2125832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M; Cullen MT; Casadei G
    Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical use of class IC antiarrhythmic drugs.
    Abi Samra F
    J La State Med Soc; 1989 May; 141(5):27-31. PubMed ID: 2499646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
    Ventosa A; Adragão P; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 1990 Jan; 9(1):33-9. PubMed ID: 1691653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained therapeutic efficacy and safety of oral propafenone for treatment of chronic ventricular arrhythmias: a 2-year experience.
    Dinh H; Baker BJ; de Soyza N; Murphy ML
    Am Heart J; 1988 Jan; 115(1 Pt 1):92-6. PubMed ID: 3336989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic efficacy of penticainide and comparison with disopyramide, flecainide, propafenone and mexiletine by acute oral drug testing.
    Priori SG; Bonazzi O; Facchini M; Varisco T; Schwartz PJ
    Am J Cardiol; 1987 Nov; 60(13):1068-72. PubMed ID: 3118693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.
    Bryson HM; Palmer KJ; Langtry HD; Fitton A
    Drugs; 1993 Jan; 45(1):85-130. PubMed ID: 7680987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group.
    Aliot E; Denjoy I
    Am J Cardiol; 1996 Jan; 77(3):66A-71A. PubMed ID: 8607394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of patients with acute atrial fibrillation in the ED.
    Conti A; Del Taglia B; Mariannini Y; Pepe G; Vanni S; Grifoni S; Abbate R; Michelucci A; Padeletti L; Gensini GF
    Am J Emerg Med; 2010 Oct; 28(8):903-10. PubMed ID: 20825922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil.
    Kingma JH; Suttorp MJ
    Am J Cardiol; 1992 Aug; 70(5):56A-60A; discussion 60A-61A. PubMed ID: 1510000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propafenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias.
    Harron DW; Brogden RN
    Drugs; 1987 Dec; 34(6):617-47. PubMed ID: 3322781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Worsening of ventricular arrhythmia in the dynamic ECG in patients treated with anti-arrhythmia drugs].
    Lanza GA; Tamburi S; Mondello Malvestiti FM; Rebuzzi AG; Lucente M
    Cardiologia; 1988 Jun; 33(6):613-8. PubMed ID: 3139292
    [No Abstract]   [Full Text] [Related]  

  • 17. Short-term and long-term treatment with propafenone: determinants of arrhythmia suppression, persistence of efficacy, arrhythmogenesis, and side effects in patients with symptoms.
    Zehender M; Hohnloser S; Geibel A; Furtwängler A; Olschewski M; Meinertz T; Just H
    Br Heart J; 1992 Jun; 67(6):491-7. PubMed ID: 1622701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oral flecainide in the treatment of refractory arrhythmias. Long-term follow-up of 98 patients].
    Haissaguerre M; Warin JF; Benchimol D; Le Métayer P; Regaudie JJ; Blanchot P
    Arch Mal Coeur Vaiss; 1987 Mar; 80(3):357-63. PubMed ID: 3113358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of long-term flecainide and propafenone in the management of patients with symptomatic paroxysmal atrial fibrillation: report from the Flecainide and Propafenone Italian Study Investigators.
    Chimienti M; Cullen MT; Casadei G
    Am J Cardiol; 1996 Jan; 77(3):60A-75A. PubMed ID: 8607393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of propafenone on ventricular arrhythmias: double-blind, parallel, randomized, placebo-controlled dose-ranging study.
    Singh BN; Kaplinsky E; Kirsten E; Guerrero J
    Am Heart J; 1988 Dec; 116(6 Pt 1):1542-51. PubMed ID: 3057844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.